4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-050670
CFO & Executive Vice President acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Dier Mardi · CFO & Executive Vice President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-09-16 | Grant or award : show line 1 in the form | +20,000 | 71,808 | D |
Loading xslF345X03/doc4.xml…